Lars I. Eriksson

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros et al. · Cell · 2020 · 2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision

Thomas Fuchs‐Buder, Casper Claudius, Lene Theil Skovgaard et al. · Acta Anaesthesiologica Scandinavica · 2007 · 618 citations · Full text

Medicine, Neurology, Pharmacology +8

Resolving postoperative neuroinflammation and cognitive decline

Niccolò Terrando, Lars I. Eriksson, Jae Kyu Ryu et al. · Annals of Neurology · 2011 · 579 citations · Full text

Life Sciences, Neuroscience, Surgery +17

Natural killer cell immunotypes related to COVID-19 disease severity

Christopher Maucourant, Iva Filipovic, Andrea Ponzetta et al. · Science Immunology · 2020 · 514 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Kinetic Analysis of Central [ ¹¹ C]Raclopride Binding to D ₂ -Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis

Lars Farde, Lars I. Eriksson, Gunnar Blomquist et al. · Journal of Cerebral Blood Flow & Metabolism · 1989 · 454 citations

Medicine, Nuclear Medicine, Pharmacology +17